Company news

Axogen, Inc. news in 2026

Axogen, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences

November 3, 2026

Axogen, Inc. Reports Third Quarter 2026 Financial Results

October 28, 2026

Axogen, Inc. to Report Third Quarter 2026 Financial Results on October 28, 2026

October 14, 2026

Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair

October 1, 2026

Axogen Announces Pricing of $208.7 Million Public Offering of Common Stock

September 10, 2026

Axogen Enters into Definitive Agreement to Acquire BioCircuit Technologies

September 10, 2026

Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference

September 1, 2026

Axogen, Inc. Reports Second Quarter 2026 Financial Results

July 29, 2026

Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026

July 15, 2026

Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference

April 30, 2026

Axogen, Inc. Reports First Quarter 2026 Financial Results

April 28, 2026

Axogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026

April 14, 2026

Conference Call Presentation FY 2025

February 25, 2026

Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results

February 23, 2026

Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

February 10, 2026

Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock

January 21, 2026

Axogen Announces Proposed Public Offering of Common Stock

January 21, 2026

J.P. Morgan 2026 Healthcare Conference

January 15, 2026

Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025

January 11, 2026

Calls in 2026

Decks in 2026